TTK Healthcare Limited
₹1,035.00▲ +2.30 (+0.22%)
TTKHLTCARE·NSE·Diversified
Market Cap
1458.74 Cr
PE Ratio
22.27
Volume
4,677
Day High - Low
1047.80 - 1023.10
52W High-Low
1247.00 - 735.00
₹1,035.00▲ +2.30 (+0.22%)
Market Cap1458.74 Cr
PE Ratio22.27
Volume4,677
Day High - Low1047.80 - 1023.10
52W High-Low1247.00 - 735.00
TTK Healthcare Limited (TTKHLTCARE): company summary
The company's annual revenue rose 7.0% to ₹857 crore, while annual net profit fell 19.9% to ₹66 crore.
TTK Healthcare Limited (TTKHLTCARE) is a micro-cap Diversified company valued at ₹1,459 crore operating in Diversified on the NSE and BSE.
- Recent price move
- TTK Healthcare Limited last traded at ₹1,035, modestly up 0.22% on the day.
- Recent developments
- On 2026-07-23, Wipro Consumer Care acquired Good Home and Eva brands from TTK Healthcare for ₹256 crore, which together generated ₹148 crore in revenue in FY26.
- Financial performance
- The company's annual revenue rose 7.0% to ₹857 crore, while annual net profit fell 19.9% to ₹66 crore. The latest quarter saw revenue increase 14.0% year-over-year to ₹258 crore, and net profit surged 63.7% to ₹21 crore, indicating improving performance in recent months.
- Valuation multiples
- The stock trades at 22.3 times earnings, a premium to the Diversified median of 12.4, 1.45 times book value. It yields 0.9%.
- Things to watch
- The company's net profit margin narrowed 2.6 percentage points to 7.7%, and profit declined 53.2% over the past three years. The stock is 17.0% below its 52-week high, and domestic institutional holdings dropped by 2.07 percentage points in the quarter.
- Where it stands
- TTK Healthcare Limited ended the latest quarter with revenue of ₹258 crore and net profit of ₹21 crore, showing a strong rebound from the previous year. The company's net profit margin and return on equity remain low, and its stock is trading below its 52-week high.
Summarised by DocStoX's model on 2026-10-18 from company filings, exchange data and news. This is a factual summary, not a rating or a recommendation. Informational only, not investment advice. Consult a SEBI-registered adviser before investing.
DocStoX Score
4.3/10
Weak
Fair Value
Sign in to see
ROE
5.89%
Weak
P/E
22.27x
Fair
Debt / Equity
0.02
Low
Industry
Diversified
Diversified
Overall View
Weak
Price performance
Day₹1023
₹1048
52W₹735.00
₹1247
DocStoX take
Supported by momentum (6.2), but held back by quality (2.5).
DocStoX score
Low confidence4.3
/10
Weak
Quality
Weak
ROE 5.9%
Valuation
Rich
P/E 22.3×
Growth
Slow
Revenue +12.5% 5Y CAGR
Risk
Moderate
D/E 0.02
Momentum
Firm
59% of 52-week range
At a glance
Market Cap
₹1,459 Cr
52W High / Low
₹1247 / ₹735
Dividend Yield
0.88%
Promoter Holding
74.56%
EPS (TTM)
₹46.48
Book Value
₹788.98
Key highlights
- Low leverage — D/E 0.02
- Profitable in all of the last 5 years
2 Positives0 Watchouts
Growth
Financials
Technicals
Peers
News
Forecasts
About the company
More data
Filings, corporate actions and ownership detail — opened on demand.
More Diversified stocks · Diversified
Explore TTK Healthcare Limited’s valuation
Free deep-dive tools · no sign-up
Fair ValueOur fair-value estimate, upside, and Bear/Base/Bull scenarios.Intrinsic ValueGraham & earnings-power intrinsic value with margin of safety.DCFDiscounted cash flow — free cash flow, growth, value per share.ValuationP/E, P/B, earnings yield and the full multiples picture.Financial RatiosProfitability, leverage and efficiency ratios at a glance.PeersHow it stacks up against its closest listed competitors.
TTK Healthcare Limited peers in Diversified
Other Diversified stocks on the NSE & BSE. See the full Diversified sector list.
Godrej Industries Limited3M India LimitedDCM Shriram LimitedKama Holdings LimitedLords Mark Industries LimitedBalmer Lawrie & Company LimitedEmpire Industries LtdEmpire Industries LtdEmpire Industries LimitedGillanders Arbuthnot & Company LimitedAspinwall and Company LimitedPanth Infinity Ltd
Compare TTK Healthcare Limited with peers
Related tools & concepts
Value TTK Healthcare Limited with the ratios and calculators DocStoX uses in its analysis.
P/E RatioPrice to earningsReturn on Equity (ROE)ProfitabilityROCECapital efficiencyDebt to EquityLeverageP/B RatioPrice to bookNet Profit MarginBottom-line efficiencyDCF / Intrinsic ValueEstimate fair valueCAGR CalculatorAnnualised returnDividend YieldIncome on pricePosition SizeRisk-based sizingBrokerage CalculatorCharges on a tradeSIP CalculatorSystematic investing